Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Medtronic - MITG
Institut Bergonié
Elevation Oncology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sumitomo Pharma America, Inc.
City of Hope Medical Center
Pfizer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
University of Kansas Medical Center
Amgen
Roswell Park Cancer Institute
Amgen
National Institutes of Health Clinical Center (CC)
Fox Chase Cancer Center
Memorial Sloan Kettering Cancer Center
Altor BioScience
National Institutes of Health Clinical Center (CC)